ceramide composition.
Ascidian is a model organism for evaluating the characteristics of vertebrates because like vertebrates, it has a notochord, which is a precursor of the backbone of a chordate. Moreover, the complete genome sequence of ascidian C. intestinalis has already been determined 9) ; a large amount of genome-related data has been accumulated using such as EST analysis and in situ hybridization 10, 11) . Research on ascidians has advanced in the post-genome era, with a focus on glycans and lipids. Recently, 2 novel acidic glycosphingolipids were detected in 2 ascidians-C. intestinalis and H. roretzi 12, 13) . Although ascidian phospholipid has not yet been isolated, sphingomyelin has been estimated on the basis of binding of lysenin to sphingomyelin.
We describe the structural characterization of sphingomyelin from an ascidian of Enterogona, C. intestinalis, and 3 other ascidian species of Pleurogona, Halocynthia roretzi, Halocynthia aurantium, and Styela clava, and the comparison of the ceramide composition of these sphingomyelins. To understand sphingomyelin and sphingomyelin-derived second messenger functions, it is first necessary to compare them in isolation and characterize sphingomyelins.
EXPERIMENTAL

1
C. intestinalis was collected at Kobe Port near Kobe University in Japan. H. roretzi, H. aurantium, and S. clava were purchased from Hiroyo Fisheries Ltd., Nishikiya Saito Ltd., and SEA Kukaku Corp., respectively, in Japan.
2
After the cellulose crusts were removed from three specimens, except C. intestinalis, these specimens were boiled, suspended in acetone, and dried naturally. The dry specimens were homogenized using a blender and extracted twice with chloroform-methanol (2:1, v/v) for 2 h and once with chloroform-methanol (1:1, v/v) overnight at room temperature. The extracts were combined and concentrated using a rotary evaporator at 40 . The crude lipid fraction was subjected to mild alkaline hydrolysis in 0.5 M KOH in methanol/water (95:5, v/v) at 37 overnight to eliminate acyl and alkenyl glycerolipids for obtaining sphingolipids. The alkali-stable product that resulted in a precipitate by cold acetone was applied to a QAE-Sephadex A-25 (GE Healthcare Bio-Sciences) column chromatography (column size, 3.4 cm 22 cm) and eluted with 3 volumes of chloroform-methanol-water (30:60:8, v/v/v) for neutral and zwitterionic sphingolipids fraction including sphingomyelins, and with 5 volumes of 0.05 M, 3 volumes of 0.15 M, and 3 volumes of 0.45 M ammonium acetate in methanol for the extraction of acidic sphingolipids fraction, respectively. The obtained neutral sphingolipids fraction including sphingomyelins was concentrated and dried by a rotary evaporator and a N 2 evaporator.
3
The obtained neutral sphingolipids fraction was acetylated by adding pyridine/acetic anhydride (2:3, v/v) and reacted at 20 for 18 h. The acetylated neutral sphingolipids fraction was applied to a Florisil (magnesium silicate; Nacalai Tesque) column chromatography (column size 1.8 cm 100 cm) to remove neutral glycosphingolipids. Three volumes of each 1,2-dichloroethane-methanol (3:1, v/v), 1,2dichloroethane-methanol-water (20:80:10, v/v/v), and chloroform-methanol-water (60:40:10, v/v/v) were eluted to obtain the acetylated neutral phosphosphingolipid fraction including sphingomyelins. This acetylated neutral phosphosphingolipid fraction (1,2-dichloroethane-methanolwater fraction) was deacetylated by 0.5 M potassium hydroxide in methanol at 37 for 12 h, and neutralized by the addition of an appropriate amount of hydrochloric acid and then dialyzed. This fraction was chromatographed to remove a phospholipid except a phospoglycerolipid of glycerol-ether type, on an Iatrobeads (silica gel 6RS-8060; Mitsubishi Kagaku Iatron, Inc.) column (column size, 2.0 cm 20 cm) with chloroform-methanol-water (60:25:8, v/v/v). The effluents were fractionated every 5 ml into a test tube using a fraction-collector and monitored by TLC. The collected sphingomyelin fraction was also confirmed by infrared absorption spectroscopy.
4
The samples were monitored by TLC using silica gel 60 plates (Merck, Germany). As running solvents, sphingomyelin, lyso-sphingomyelin (sphingosylphosphorylcholine), and ceramide were developed with chloroformmethanol-water (60:40:10, v/v/v), chloroform-methanolwater-acetic acid (60:40:10:10, v/v/v/v), and chloroformmethanol (92:8, v/v), respectively. The sphingomyelins were visualized by spraying with the Dittmer-Lester reagent 14) and the Hanes-Isherwood reagent 15) for phosphorus, ninhydrin reagent for free amino groups and 50%-H 2 SO 4 regent for ceramides. Cellulose thin-layer plates were used for the TLC of the phosphocholine (Funakoshi Corp.), which was developed using butanol-acetic acidwater (40:10:20, v/v/v) as a running solvent, and visualized using the Hanes-Isherwood regent for phosphorus.
5
The sample (~100 mg) dissolved as 1 mg/mL concentration with chloroform-methanol (2:1, v/v) was dried on the cr ystal plate and analyzed using Fourier transform infrared absorption spectrophotometer, Shimadzu FTIR-8400S equipped with MIRacle TM A.
6
To obtain hydrolyzates including lyso-sphingomyelin and fatty acids from sphingomyelin, acid hydrolysis was carried out by treatment of the sphingomyelins (2 mg) with 6 M butanol-hydrochloric acid (0.5 mL) at 100 for 1 h. These hydrolyzates were washed in acetone three times to remove free fatty acids. The remaining hydrolyzates, crude lyso-sphingomyelin, were chromatographed on an Iatrobeads column (column size, 1.0 cm 12 cm) by stepwise elution with chloroform-methanol (80:20, v/v, 70:30, v/v, and 60:40, v/v) and chloroform-methanol-water (60:40:10, v/v/v). The obtained purified lyso-sphingomyelin was analyzed by infrared absorption spectroscopy and TLC with chloroform-methanol-acetic acid-water (60:40:10:10, v/v/v) as a running solution.
7
The sample (2 mg) was dissolved in 0.5 mL of dimethylsulfoxide and hydrogen fluoride was added to this lysate, and then allowed to stand at room temperature for 20 h. To obtain the ceramide fraction, this solution was dialyzed with running water and freeze-dried. The obtained ceramide fraction was analyzed by TLC with chloroformmethanol (92:8, v/v) as a running solution.
8
Sphingomyelin (2 mg) was dissolved in 0.2 ml of 50 mM Tris-HCl (pH 7.5) buffer with 0.1 mL of 20 mM CaCl 2 and 0.2 mL of ethyl-ether, and was then enzymatically hydrolyzed by phospholipase C in 0.1 mL of 50 mM Tris-HCl (pH 7.5) buffer at 37 for 34 h. The hydrolyzed sphingomyelin solution was heated to remove ethyl-ether and 2 mL of chloroform-water (2:1, v/v) was added to separate using the Folch partition. The lower solution was dried and analyzed by TLC with chloroform-methanol (92:8, v/v) as a running solution.
9
Sphingoids were prepared from sphingomyelins by methanolysis with 1M aqueous methanolic HCl at 70 for 18 h. The O-trimethylsilyl derivatives of sphingoids were analyzed using the Shimadzu GC-18A gas chromatograph with the Shimadzu HiCap-CBP5 (0.22 mm 25 m) programmed at 2 /min from 210 to 230 . Fatty acids were prepared from sphingomyelins by hydrolysis with 1 M aqueous methanolic HCl at 100 for 3 h. The fatty acid methyl esters were extracted three times using 0.5 mL of n-hexane and then analyzed using the Shimadzu GC-18A gas chromatograph with the Shimadzu HiCap-CBP5 (0.22 mm 25 m) programmed at 2 /min from 170 to 230 .
10
The sphingomyelin was prepared as a 1 mg/mL solution in chloroform/methanol (2:1, v/v). It was separately put on a plate in the order of sphingomyelin and matrix solution (1:1, v/v; 4 mg/mL), and was crystallized by natural drying. The matrix used a-CHCA (a-Cyano-4-hydroxycinnamic acid; Wako Pure Chem. Industries Ltd. Japan). The MS spectra were calibrated externally using a standard peptide calibration mixture containing 1 mg/mL each of angiotensin I (1,296.68 Mass Units; Wako Pure Chem. Industries Ltd. Japan) and bradykinin fragments 1-5 (573.31 Mass Units; Sigma Chemical Co.). MALDI-TOF MS analysis was performed using an Applied Biosystems/Voyager-DE TM STR Biospectrometer with a nitrogen laser (337 nm) and an acceleration voltage of 20 kV, operating in the reflector positive ion mode.
RESULTS
1
C intestinalis By using chloroform/methanol solution, lipid (14.0 g) was extracted from the dried powder (400.0 g) of the ascidian C. intestinalis, was treated to mild-alkali hydrolysis. The obtained alkali-stable substances (7.85 g) were applied to a QAE-Sephadex column. The lipid fraction (3.0 g) including sphingomyelin was recovered from the QAE-Sephadex column with chloroform/methanol/water as the pass-through fraction (
). Then, this lipid fraction was purified by Florisil column chromatography after acetylation. The phosphosphingolipid fraction including sphingomyelin was deacetylated and returned to the original state (373 mg). Finally, 27.3 mg of sphingomyelin was isolated from 50.0 mg of phosphosphingolipid fraction by Iatrobeads column chromatography with chloroform/methanol/water (60:25:3, v/v/v) ( ).
2
Sphingomyelin of C. intestinalis was identified by the following analyses.
Infrared absorption spectroscopy analysis
The sphingomyelin of C. intestinalis was analyzed using IR. As a result, three sphingomyelin-specific absorptions, that is, the amide bond (1,550 cm -1 and 1,650 cm -1 ), phosphorus-oxygen bond (1,220 cm -1 ), and choline group (960 cm -1 ) were observed ( ).
Butanol-hydrochloric acid hydrolysis
Lyso-sphingomyelin is produced from sphingomyelin by the butanol-hydrochloric acid hydrolysis. The resolvent produced from sphingomyelin from C. intestinalis by butanol-hydrochloric acid hydrolysis was analyzed by TLC and IR spectroscopy. Sphingomyelin shows a positive reaction only to the Dittmer-Lester reagent but the resolvent after hydrolysis showed positive reactions to both Dittmer-Lester and ninhydrin reagents (data not shown). In the IR analysis, no amide bond absorption of the resolvent was M. Ito, K. Yokoi, T. Inoue et al.
observed in comparison with sphingomyelin ( ).
Hydrogen fluoride degradation analysis
Ceramide is produced from sphingomyelin by hydrogen fluoride degradation treatment. The obtained reaction products by hydrogen fluoride treatment were purified by Iatorobeads chromatography. The purified product was analyzed by TLC and IR spectroscopy. By TLC analysis, the band of the product migrated to a similar position as with that of a standard ceramide (data not shown). In addition, the IR spectra of the product did not show absorptions of choline group and the hydroxyl group of phosphate, but did show the absorption of amide bond from ceramide ( ).
Enzymatic hydrolysis
A phosphocholine and a ceramide were produced by the phospholipase C treatment ( ). The reaction products by phospholipase C hydrolysis were purified by Iatorobeads chromatography. On TLC analysis, the puri- 
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fied product showed the same Rf value as that of ceramide obtained by the hydrogen fluoride treatment.
3
The ceramide moiety of C. intestinalis sphingomyelin was characterized by CG and CG-MS analyses ( ). The fatty acids were mainly composed of C16:0, C18:0, and C18:1 and the sphingoids were composed entirely of d16:1 sphingenine and d18:2 sphingadiene.
4
The putative structure of the sphingomyelin purified from C. intestinalis was confirmed by MALDI-TOF MS analysis in the reflector positive-ion mode ( ). A sum- ). These peaks were detected with [M+Na] + or [M+H ] + ionization. The difference in each molecular mass was ~14 Da respectively, for instance, between m/z 723.44, 737.45, and 751.47 as corresponding to the molecular mass of CH 2 from the different ceramide composition.
5
Sphingomyelins of 3 species of ascidians H. roretzi, H. aurantium, and S. clava, which belong to a different order than that of C. intestinalis, were isolated using the same preparation.
shows the yields at each fraction stage and the sphingomyelin content from each ascidian. The structures of the sphingomyelin were determined by the methods mentioned above. Characterization of these ceramide moieties was performed by CG and CG-MS analyses ( ).
DISCUSSION
Most of the phosphosphingolipid in vertebrates is in the form of sphingomyelin, but it has been thought that this is not the case in invertebrates. In fact, the phosphosphingolipid identified in invertebrates is present as ceramide phosphoethanolamine [3] [4] [5] and ceramide aminoethylphosphonate 1 6 -1 7 ) , other wise sphingomyelin has rarely been observed. Recently, the presence of sphingomyelin has been found in vertebrates using lysenin, a sphingomyelinspecific toxin 5, 6) . However, there is insufficient data to decide the existence of the sphingomyelin in the invertebrates based on results from only the above analysis. It is necessary to isolate and characterize the sphingomyelin in order to understand the sphingomyelin function.
In this study, we first isolated sphingomyelin and identified its structure from the ascidian C. intestinalis of Enterogona. Next, we identified the sphingomyelin struc- acids were observed in Pleurogona ascidians. Thus, the major components of the ceramide moiety were similar across the species, but the minor components differed. The yields of sphingomyelin in each ascidian were also similar ( ). We have identified novel acidic glycosphingolipids, sulfated glycosphingolipid (SGL-1) 12) and uronic acid-contained glycosphingolipid (UGL-1) 13) , and several neural glycosphingolipids (in preparations) from 2 ascidians, C. intestinalis (Enterogona) and H. roretzi (Pleurogona). The major components of the ceramide moiety of SGL-1 consisted of C16:0, 2-hydroxy-C21:0 and 2-hydroxy-C22:0 fatty acids and C16-, C17-, branched C17-, C18-and branched C18-phytosphingosines, while that of the ceramide moiety of UGL-1 consisted of C16:0 and C18:0 fatty acids and C16-, C17-and C18-phytosphingosines. The ceramide components of neutral glycosphingolipids from C. intestinalis and H. roretzi were very similar to that of acidic glycosphingolipids. Therefore, ceramide glycosyltransferase and ceramide cholinephosphotransferase could specifically recognize and/or distinguish the different ceramide components on glycosphingolipid and sphingomyelin biosynthesis.
